Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 54 min ago
Peer-reviewedCC BY 4.0BMC Public Health

Lifestyle risk factors for cervical glandular and squamous cell neoplasia: insights from a prospective cohort study of over 117,000 women

Abstract

Background: While cervical cancer screening has successfully reduced squamous cell carcinoma (SCC) rates, adenocarcinoma (AC) incidence is rising, particularly among younger women. Although SCC and AC differ in genomics and treatment responses, evidence regarding their distinct lifestyle risk factors remains limited. To address this gap, this prospective cohort study investigates lifestyle-related risk factors specifically associated with high-grade glandular and with squamous cervical lesions compared to the unaffected women.

Methods: One hundred seventeen thousand five hundred eleven women, from Norway, Sweden, Denmark, and Iceland aged 18–45 years who completed a questionnaire on cervical neoplasia risk factors, were followed for a mean of 9.5 years for cervical precancer and cancer.

Results: Altogether, 23 women were subsequently diagnosed with AC and 66 with SCC, while 174 were found to have adenocarcinoma in situ (AIS) and 2,926 had cervical intraepithelial neoplasia grade 3 (CIN3). Compared to unaffected women, those diagnosed with AIS/AC or CIN3/SCC reported earlier age at first intercourse and more lifetime sexual partners. Multivariate analysis revealed different risk profiles: CIN3/SCC risk was independently associated with number of sexual partners (adjusted HR = 1.47, 95% CI: 1.34–1.56), hormonal contraceptive use (adjusted HR = 1.23, 95% CI: 1.02–1.47), history of chlamydia (adjusted HR = 1.43, 95% CI: 1.31–1.56), and smoking (adjusted HR = 1.02 per pack-year, 95% CI: 1.02–1.03). In contrast, history of genital warts was specifically associated with AIS/AC (adjusted HR = 1.60, 95% CI: 1.15–2.24).

Conclusion: These findings highlight the importance of targeted prevention strategies, including development risk-based screening models, improving adherence to screening guidelines, for both glandular and squamous cell cervical lesions. Filling this knowledge gap is vital for achieving the WHO’s cervical cancer elimination goals.

Related

  1. Ambient air pollution and ocular surface squamous neoplasia: a case-control study in Tehran, Iran
    Mozhgan Rezaei Kanavi, Abbas Shahsavani, Narges Khanjani +8
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textPharmacology & toxicologyCrossref
  2. Cytokine Profiles in Cervical Intraepithelial Neoplasia: Associations with Lesion Severity and Exploratory Treatment Response
    Attila Louis Major, Aleksandra Riger, Nataliy Kharchenko +5
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Real-world clinical outcomes of 5-aminolevulinic acid photodynamic therapy in patients with cervical intraepithelial neoplasia grade 1
    Tianci Fan, Lina Geng, Guanwen Gao +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMCPMC
  4. cGAS-STING pathway-related genes as candidate molecules associated with cervical intraepithelial neoplasia: an exploratory bioinformatics analysis
    Ting Liu, ZhengDe OuYang, WenJin Wu +3
    Discover OncologyPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
  5. Evaluation of HPV E6/E7 mRNA in predicting recurrence after Leep in cervical intraepithelial neoplasia: A study of negative findings
    Yingmei Huang, Jianyong Huang, Hongmian Jiang +3
    PLOS OnePeer-reviewedCC BY 4.0Full textMicrobiologyInfectious diseasePLOS
BibTeX
@article{orumaa2026lifestyle,
  title = {{Lifestyle risk factors for cervical glandular and squamous cell neoplasia: insights from a prospective cohort study of over 117,000 women}},
  author = {Madleen Orumaa and Susanne K. Kjaer and Christian Munk and Karin Sundström and Laufey Tryggvadóttir and Suzanne Campbell and Thea E. Hetland Falkenthal and Ståle Nygård and Mari Nygård},
  journal = {BMC Public Health},
  year = {2026},
  month = oct,
  doi = {10.1186/s12889-026-29877-7},
  url = {https://link.springer.com/article/10.1186/s12889-026-29877-7},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Lifestyle risk factors for cervical glandular and squamous cell neoplasia: insights from a prospective cohort study of over 117,000 women
AU  - Madleen Orumaa
AU  - Susanne K. Kjaer
AU  - Christian Munk
AU  - Karin Sundström
AU  - Laufey Tryggvadóttir
AU  - Suzanne Campbell
AU  - Thea E. Hetland Falkenthal
AU  - Ståle Nygård
AU  - Mari Nygård
PY  - 2026
DA  - 2026/10/15
JO  - BMC Public Health
DO  - 10.1186/s12889-026-29877-7
UR  - https://link.springer.com/article/10.1186/s12889-026-29877-7
AB  - Background: While cervical cancer screening has successfully reduced squamous cell carcinoma (SCC) rates, adenocarcinoma (AC) incidence is rising, particularly among younger women. Although SCC and AC differ in genomics and treatment responses, evidence regarding their distinct lifestyle risk factors remains limited. To address this gap, this prospective cohort study investigates lifestyle-related risk factors specifically associated with high-grade glandular and with squamous cervical lesions compared to the unaffected women.  Methods: One hundred seventeen thousand five hundred eleven women, from Norway, Sweden, Denmark, and Iceland aged 18–45 years who completed a questionnaire on cervical neoplasia risk factors, were followed for a mean of 9.5 years for cervical precancer and cancer.  Results: Altogether, 23 women were subsequently diagnosed with AC and 66 with SCC, while 174 were found to have adenocarcinoma in situ (AIS) and 2,926 had cervical intraepithelial neoplasia grade 3 (CIN3). Compared to unaffected women, those diagnosed with AIS/AC or CIN3/SCC reported earlier age at first intercourse and more lifetime sexual partners. Multivariate analysis revealed different risk profiles: CIN3/SCC risk was independently associated with number of sexual partners (adjusted HR = 1.47, 95% CI: 1.34–1.56), hormonal contraceptive use (adjusted HR = 1.23, 95% CI: 1.02–1.47), history of chlamydia (adjusted HR = 1.43, 95% CI: 1.31–1.56), and smoking (adjusted HR = 1.02 per pack-year, 95% CI: 1.02–1.03). In contrast, history of genital warts was specifically associated with AIS/AC (adjusted HR = 1.60, 95% CI: 1.15–2.24).  Conclusion: These findings highlight the importance of targeted prevention strategies, including development risk-based screening models, improving adherence to screening guidelines, for both glandular and squamous cell cervical lesions. Filling this knowledge gap is vital for achieving the WHO’s cervical cancer elimination goals.
SN  - 1471-2458
ER  -